JP2016529223A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016529223A5 JP2016529223A5 JP2016523852A JP2016523852A JP2016529223A5 JP 2016529223 A5 JP2016529223 A5 JP 2016529223A5 JP 2016523852 A JP2016523852 A JP 2016523852A JP 2016523852 A JP2016523852 A JP 2016523852A JP 2016529223 A5 JP2016529223 A5 JP 2016529223A5
- Authority
- JP
- Japan
- Prior art keywords
- rv1733c
- mtb
- rv2626c
- mtb antigen
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000427 antigen Substances 0.000 claims 30
- 102000036639 antigens Human genes 0.000 claims 30
- 108091007433 antigens Proteins 0.000 claims 30
- 101100103958 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Rv1733c gene Proteins 0.000 claims 13
- 239000013598 vector Substances 0.000 claims 13
- 239000000203 mixture Substances 0.000 claims 12
- 108020001507 fusion proteins Proteins 0.000 claims 11
- 102000037865 fusion proteins Human genes 0.000 claims 11
- 241001217856 Chimpanzee adenovirus Species 0.000 claims 9
- 101100395578 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) hrp1 gene Proteins 0.000 claims 9
- 208000002606 Paramyxoviridae Infections Diseases 0.000 claims 6
- 241000700605 Viruses Species 0.000 claims 6
- 101710088334 Diacylglycerol acyltransferase/mycolyltransferase Ag85B Proteins 0.000 claims 4
- -1 ESAT6 Proteins 0.000 claims 4
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims 4
- 101100156500 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) vapB47 gene Proteins 0.000 claims 4
- 101150053438 PPE51 gene Proteins 0.000 claims 4
- 230000001154 acute effect Effects 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 241001135569 Human adenovirus 5 Species 0.000 claims 3
- 241001135572 Human adenovirus E4 Species 0.000 claims 3
- 206010046865 Vaccinia virus infection Diseases 0.000 claims 3
- 208000007089 vaccinia Diseases 0.000 claims 3
- 239000013603 viral vector Substances 0.000 claims 3
- 101100445609 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) espC gene Proteins 0.000 claims 2
- 101150082852 PPE15 gene Proteins 0.000 claims 2
- 239000000443 aerosol Substances 0.000 claims 2
- 101150014428 mpt64 gene Proteins 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 201000008827 tuberculosis Diseases 0.000 claims 2
- 239000013604 expression vector Substances 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361838872P | 2013-06-25 | 2013-06-25 | |
| US61/838,872 | 2013-06-25 | ||
| PCT/US2014/043889 WO2014210018A1 (en) | 2013-06-25 | 2014-06-24 | Tuberculosis compositions and methods of using the same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019124873A Division JP7269806B2 (ja) | 2013-06-25 | 2019-07-04 | 結核組成物及びそれを使用する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016529223A JP2016529223A (ja) | 2016-09-23 |
| JP2016529223A5 true JP2016529223A5 (enExample) | 2017-08-03 |
| JP6554095B2 JP6554095B2 (ja) | 2019-07-31 |
Family
ID=52111114
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016523852A Active JP6554095B2 (ja) | 2013-06-25 | 2014-06-24 | 結核組成物及びそれを使用する方法 |
| JP2019124873A Active JP7269806B2 (ja) | 2013-06-25 | 2019-07-04 | 結核組成物及びそれを使用する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019124873A Active JP7269806B2 (ja) | 2013-06-25 | 2019-07-04 | 結核組成物及びそれを使用する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US10266574B2 (enExample) |
| EP (2) | EP3013364B1 (enExample) |
| JP (2) | JP6554095B2 (enExample) |
| CN (1) | CN105431166B (enExample) |
| ES (1) | ES2925950T3 (enExample) |
| WO (1) | WO2014210018A1 (enExample) |
| ZA (1) | ZA201509262B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014009438A2 (en) * | 2012-07-10 | 2014-01-16 | Transgene Sa | Mycobacterial antigen vaccine |
| WO2014210018A1 (en) | 2013-06-25 | 2014-12-31 | Aeras Global Tb Vaccine Foundation | Tuberculosis compositions and methods of using the same |
| US10765731B2 (en) | 2014-01-09 | 2020-09-08 | Transgene Sa | Fusion of heterooligomeric mycobacterial antigens |
| WO2016120489A2 (en) * | 2015-02-01 | 2016-08-04 | Theravectys | Lentiviral vectors for expression of mycobacterium tuberculosis antigens |
| CN109890411A (zh) * | 2016-06-16 | 2019-06-14 | 国际艾滋病疫苗行动组织公司 | 结核病组合物和治疗或预防结核病的方法 |
| CN109843321A (zh) * | 2016-06-22 | 2019-06-04 | 国际艾滋病疫苗行动组织公司 | 作为结核病疫苗的重组巨细胞病毒载体 |
| ES2950436T3 (es) | 2016-12-14 | 2023-10-10 | Becton Dickinson Co | Métodos y composiciones para obtener una valoración de tuberculosis en un sujeto |
| CN108239660B (zh) * | 2016-12-26 | 2021-08-10 | 上海生物制品研究所有限责任公司 | 一种重组结核病疫苗，其制备方法及应用 |
| WO2018236876A2 (en) * | 2017-06-19 | 2018-12-27 | Washington University | Nanoemulsion and methods of use thereof |
| US11638749B2 (en) | 2017-10-17 | 2023-05-02 | International Aids Vaccine Initiative, Inc. | Tuberculosis antigen cassettes |
| KR102135334B1 (ko) * | 2018-12-19 | 2020-07-17 | 대한민국 | 결핵 다가 항원을 발현하는 재조합 아데노 바이러스 및 이를 포함하는 결핵 예방용 조성물 |
| CN116327906B (zh) * | 2021-12-22 | 2026-03-20 | 中国人民解放军总医院第八医学中心 | 一种结核分枝杆菌串联dna疫苗w545及其制备方法与应用 |
| CN116655754A (zh) * | 2023-03-31 | 2023-08-29 | 中国疾病预防控制中心传染病预防控制所 | 一种抗原组合物及其应用 |
| CN117777259B (zh) * | 2024-02-23 | 2024-06-07 | 上海科新生物技术股份有限公司 | 检测结核感染的抗原组合物、试剂盒及其应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US21579A (en) | 1858-09-21 | Rotary valve fob steam-engines | ||
| WO1993024640A2 (en) | 1992-06-04 | 1993-12-09 | The Regents Of The University Of California | Methods and compositions for in vivo gene therapy |
| WO1994016737A1 (en) | 1993-01-26 | 1994-08-04 | Weiner David B | Compositions and methods for delivery of genetic material |
| US5593972A (en) | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
| US5962428A (en) | 1995-03-30 | 1999-10-05 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
| KR101329323B1 (ko) | 2004-12-01 | 2013-11-14 | 아에라스 글로벌 티비 백신 파운데이션 | 엔도솜을 이탈하는 능력이 보강된 재조합 비씨지 균주 |
| CA2836319A1 (en) | 2005-06-23 | 2006-12-28 | Statens Serum Institut | Tuberculosis vaccines comprising antigens expressed during the latent infection phase |
| CN101432016A (zh) * | 2005-12-15 | 2009-05-13 | Aeras全球Tb疫苗基金会 | 减毒的分枝杆菌的新引发-加强组合 |
| BRPI0809926B8 (pt) * | 2007-04-04 | 2021-05-25 | Infectious Disease Res Inst | composição que compreende antígenos de mycobacterium tuberculosis, polipeptídeo de fusão isolado, polinucleotídeo isolado que codifica o dito polipeptídeo e uso da dita composição para estimular uma resposta imune protetora |
| US7670609B2 (en) | 2007-11-27 | 2010-03-02 | Aeras Global Tb Vaccine Foundation | Recombinant BCG tuberculosis vaccine designed to elicit immune responses to Mycobacterium tuberculosis in all physiological stages of infection and disease |
| US8361482B2 (en) | 2007-11-27 | 2013-01-29 | Aeras Global Tb Vaccine Foundation | Recombinant BCG tuberculosis vaccine designed to elicit immune responses to mycobacterium tuberculosis in all physiological stages of infection and disease |
| CN101289496B (zh) | 2008-05-30 | 2011-06-29 | 中国医学科学院医学生物学研究所 | 能激发机体抗结核杆菌的保护性免疫反应的抗原表位筛选方法及用途 |
| US20120244173A1 (en) | 2009-04-28 | 2012-09-27 | Tzyy-Choou Wu | Compositions and Methods for Enhancing Antigen-Specific Immune Responses |
| GB0918154D0 (en) * | 2009-10-16 | 2009-12-02 | Isis Innovation | Mycobacterial vaccines |
| WO2011052771A1 (ja) * | 2009-11-02 | 2011-05-05 | 国立大学法人三重大学 | パラミクソウイルスベクターを用いた経鼻噴霧型結核ワクチン |
| UA110103C2 (uk) * | 2010-01-27 | 2015-11-25 | Ґлаксосмітклайн Байолоджікалз С.А. | Модифікований туберкульозний антиген |
| US20120003256A1 (en) | 2010-03-01 | 2012-01-05 | Huiling Han | Tuberculosis antigens, immunogenic compositions, diagnostics and methods related to the same |
| GB201008512D0 (en) * | 2010-05-21 | 2010-07-07 | Health Prot Agency | Mycobacterial antigen composition |
| WO2014009438A2 (en) * | 2012-07-10 | 2014-01-16 | Transgene Sa | Mycobacterial antigen vaccine |
| WO2014210018A1 (en) | 2013-06-25 | 2014-12-31 | Aeras Global Tb Vaccine Foundation | Tuberculosis compositions and methods of using the same |
| CN104474538A (zh) | 2014-08-13 | 2015-04-01 | 华中科技大学 | 一种重组卡介苗 |
-
2014
- 2014-06-24 WO PCT/US2014/043889 patent/WO2014210018A1/en not_active Ceased
- 2014-06-24 CN CN201480040735.5A patent/CN105431166B/zh active Active
- 2014-06-24 ES ES14817274T patent/ES2925950T3/es active Active
- 2014-06-24 JP JP2016523852A patent/JP6554095B2/ja active Active
- 2014-06-24 EP EP14817274.5A patent/EP3013364B1/en active Active
- 2014-06-24 EP EP22188098.2A patent/EP4176897A1/en active Pending
- 2014-06-24 US US14/313,694 patent/US10266574B2/en active Active
-
2015
- 2015-12-18 ZA ZA2015/09262A patent/ZA201509262B/en unknown
-
2019
- 2019-03-01 US US16/289,919 patent/US11014969B2/en active Active
- 2019-07-04 JP JP2019124873A patent/JP7269806B2/ja active Active
-
2021
- 2021-04-21 US US17/236,409 patent/US11787842B2/en active Active
-
2023
- 2023-09-06 US US18/461,754 patent/US20240101612A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106659777A8 (zh) | 免疫原性组合产品 | |
| JP2015533841A5 (enExample) | ||
| JP2017048194A5 (enExample) | ||
| JP2013539454A5 (enExample) | ||
| WO2014159822A3 (en) | Human antibodies to respiratory syncytial virus f protein and methods of use thereof | |
| WO2015142671A3 (en) | Influenza virus vectors and uses therefor | |
| EA201892648A1 (ru) | Вирусы пичинде с трехсегментным геномом в качестве векторных вакцин | |
| ATE497785T1 (de) | Sequenzielle freisetzung immunogener moleküle über adenoviren und adeno-assoziierte viren vermittelte abgaben | |
| JP2017505605A5 (enExample) | ||
| WO2006113214A3 (en) | Vaccine against pandemic strains of influenza viruses | |
| JP2013172734A5 (enExample) | ||
| WO2014063704A8 (en) | M. tuberculosis vaccines | |
| JP2015524794A5 (enExample) | ||
| WO2012106231A3 (en) | Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza a viruses | |
| EA201891945A2 (ru) | Вакцина рекомбинантного модифицированного вируса осповакцины анкара (mva) респираторно-синцитиального вируса (rsv) | |
| JP2015524422A5 (enExample) | ||
| WO2012048817A3 (en) | Recombinant modified vaccinia virus ankara (mva) influenza vaccine | |
| CY1119518T1 (el) | Τροποποιημενα αντιγονα φυματιωσης | |
| IL286629A (en) | Multi-respiratory virus antigen-specific t cells and methods of making and using the same therapeutically | |
| Garg et al. | Development of novel carrier (s) mediated tuberculosis vaccine: More than a tour de force | |
| EA201890042A1 (ru) | Вакцина против вируса ящура (вя) на основе рекомбинантного модифицированного вируса осповакцины анкара (mva) | |
| WO2016149643A3 (en) | Fusion proteins comprising modified alpha virus surface glycoproteins and tumor associated antigen and methods thereof | |
| JP2016523943A5 (enExample) | ||
| MX358507B (es) | Antigenos vacunales quimericos contra el virus de la hepatitis c. | |
| WO2016169467A8 (zh) | 使用仙台病毒作为载体的抗结核杆菌疫苗 |